MedTrace Logo

Analysis of Surgical and Oncologic Outcomes After Complete Mesocolic Excision or Non-complete Mesocolic Excision for Right-Sided Colon Cancer

NCT06684223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3787

Last updated 2024-11-20

No results posted yet for this study

Summary

The goal of this observational study is to investigate the efficacy and safety of a modified D3 lymphadenectomy approach compared to Complete Mesocolic Excision (CME) in patients with right-sided colon cancer. The main question it aims to answer is:

Does a modified D3 approach improve disease-free survival (DFS) in patients with Stage I-III right-sided colon cancer who undergo right-sided colectomy, without increasing surgical complications compared to CME?

Patients with right-sided colon cancer, Stage I-III, who undergo either modified D3 lymphadenectomy or CME as part of their standard treatment, will have their DFS, complications, bleeding volume, number of lymph nodes harvested, and stage distribution compared over a follow-up period. This study ultimately aims to determine the optimal surgical approach for maximizing oncologic outcomes in right-sided colon cancer.

Conditions

  • Colon Cancer
  • Laparoscopic Colon Surgery
  • Lymph Node Dissection
  • Robotic Surgical Procedures

Sponsors & Collaborators

  • Korea University Anam Hospital

    collaborator OTHER

  • Kyungpook National University Chilgok Hospital

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Asan Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2020-12-31
Completion
2024-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06684223 on ClinicalTrials.gov